Attenuation of Paired-Pulse Facilitation Associated With Synaptic Potentiation Mediated by Postsynaptic Mechanisms

Jin-Hui Wang and Paul T. Kelly

Department of Neurobiology and Anatomy, University of Texas Medical School at Houston, Houston, Texas 77030

    ABSTRACT
Abstract
Introduction
Methods
Results
Discussion
References

Wang, Jin-Hui and Paul T. Kelly. Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. J. Neurophysiol. 78: 2707-2716, 1997. The relationship between paired-pulse facilitation (PPF) and synaptic potentiation induced by various protocols and their cellular and molecular mechanisms were examined by extracellular field potential and current- or voltage-clamp recordings at CA1 synapses in rat hippocampal slices. Microelectrodes were used for both intracellular recordings and injections of modulators of calcium (Ca2+) and Ca2+/calmodulin (CaM) signaling pathways into postsynaptic neurons. Basal synaptic transmission was not accompanied by changes in PPF. Tetanic stimulation induced long-term potentiation (LTP) of synaptic transmission and attenuated PPF. Experiments stimulating two independent Schaffer collateral/commisural(S/C) pathways showed that PPF attenuation and tetanus-LTP were pathway specific. Postsynaptic injections of pseudosubstrate inhibitors of CaM-dependent protein kinase II and protein kinase C (CaM-KII/PKC), [Ala286]CaMKII286-302 plus PKC19-31, almost completely attenuated tetanus-LTP and reversed PPF attenuation but did not affect synaptic transmission and PPF under basal conditions. Postsynaptic injections of heparin and dantrolene (inhibitors of IP3 and ryanodine receptors at intracellular Ca2+ stores) prevented tetanus-LTP induction and PPF attenuation. Postsynaptic injections of calcineurin (CaN) inhibitors, CaN autoinhibitory peptide (CaN-AIP) or FK-506, enhanced synaptic transmission and decreased PPF. CaN-inhibited synaptic potentiation and PPF attenuation were unaffected by D(-)-a-Amino-5-phosphonopentanoic, but blocked by coinjecting 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, heparin plus dantrolene, calmodulin-binding peptide, or [Ala286]CaMKII281-302 plus PKC19-31. PPFattenuation associated with tetanus-LTP or CaN-inhibited synaptic potentiation resulted from smaller increases in the potentiation of the second synaptic responses (R2) compared with the potentiation of the first responses (R1). Our results indicate that PPF attenuation is associated with synaptic potentiation mediated by postsynaptic mechanisms, and postsynaptic Ca2+/CaM signaling pathways play a dual role in synaptic plasticity. CaN activity limits synaptic transmission under basal conditions, whereas the activation of Ca2+-dependent protein kinases enhances synaptic transmission and attenuates PPF at central synapses.

    INTRODUCTION
Abstract
Introduction
Methods
Results
Discussion
References

Synaptic facilitation, a short-term synaptic plasticity (Magleby 1987; Zucker 1989), has been observed at many chemical synapses (Feng 1941; Katz and Miledi 1968; Kuno 1964; Magleby 1973; Martin and Pilar 1964; McNaughton 1982; Porter 1970; Zengel et al. 1980). It has been shown that synaptic facilitation is associated with increases in presynaptic Ca2+ levels and transmitter release (Charlton et al. 1982; Dudel and Kuffler 1961; Katz and Miledi 1967; Llinas et al. 1981; Mallart and Martin 1967, 1968; Miledi and Parker 1981; Miledi and Thies 1971), which indicates that presynaptic residual calcium is responsible for synaptic facilitation, i.e., residual calcium hypothesis (Magleby 1987; Zucker 1989). This hypothesis is used traditionally to explain paired-pulse facilitation (PPF) of central synaptic transmission (Christie and Abraham 1994; Creager et al. 1980; Manabe et al. 1993; McNaughton 1982; Muller and Lynch 1989; Schulz et al. 1994). It is noteworthy that presynaptic residual Ca2+ as the sole mechanism for PPF has been questioned (Blundon et al. 1993; Winslow et al. 1994), alternative mechanisms may be involved in regulating synaptic facilitation (Chapman et al. 1995; Nathan and Lambert 1991; Nathan et al. 1990), and postsynaptic Ca2+/CaM signaling pathways that alter alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor properties appear to regulate the magnitude of synaptic facilitation (Wang and Kelly 1996b). Thus a complete understanding of the mechanisms for synaptic facilitation should include that increases in transmitter release by residual Ca2+ generate PPF and the responsiveness of AMPA receptors modified by postsynaptic Ca2+ and Ca2+/CaM signaling pathways regulate PPF magnitude.

Long-term potentiation (LTP) of synaptic transmission triggered by electrical stimuli (Bliss and Gardner-Medwin 1973; Bliss and Lomo 1973) or biochemicals (Kang and Schulman 1995; Malenka et al. 1986; Wang and Kelly 1995) is believed to be one of the cellular bases of learning and memory in mammalians. While addressing the location of LTP expression (pre- or postsynaptic), a frequent criteria is to identify if PPF is changed. Synaptic potentiation followed by a change in PPF is attributed to presynaptic mechanisms (Christie and Abraham 1994; Kuhnt and Voronin 1994; Schulz et al. 1994, 1995; Voronin and Kuhut 1990), which is based on the presynaptic origin for PPF. A few reports have shown no PPF change during LTP and argued that postsynaptic mechanisms are responsible for LTP (Gustafsson et al. 1988; Manabe et al. 1993). If the magnitude of PPF also is regulated by postsynaptic mechanisms, as previously shown (Wang and Kelly 1996b), the conclusion that synaptic potentiation with PPF changes are due to presynaptic mechanisms should be made with caution. In other words, changes in PPF may not serve as a criteria for judging the location of LTP expression. We have shown that postsynaptic Ca2+/CaM signaling pathways and AMPA receptor responsiveness regulate synaptic transmission and synaptic facilitation (Wang and Kelly 1995, 1996a,b). To provide further evidence for our notion as well as to better understand how postsynaptic mechanisms regulate the facilitation and potentiation of synaptic transmission, we conducted a variety of postsynaptic manipulations to reexamine the relationship between synaptic potentiation and synaptic facilitation and to address the cellular location of PPF regulation.

    METHODS
Abstract
Introduction
Methods
Results
Discussion
References

Transverse hippocampal slices were prepared from male Harlan Sprague-Dawley rats (6-7 wk) with a McIlwain tissue chopper in ice-cold standard medium (gassed with 95% O2-5% CO2) as previously described (Wang and Kelly 1995, 1996a,b). Slices were incubated in standard medium at 25°C for >1 h and then transferred to a submersion chamber (31°C; 2 ml/min perfusion rate) for electrophysiological experiments. Standard medium contained (in mM) 124 NaCl, 3 KCl, 1.3 NaH2PO4, 26 NaHCO3, 2.4 MgCl2, 2.4 CaCl2, 10 dextrose, and 10 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 7.25). To reduce the effects of gamma -aminobutyric acid (GABAA)-mediated inhibitory components on excitable synaptic transmission, experiments were conducted in the presence of bicucullin plus picrotoxin (10 µM each). In addition, orthodromic stimulating electrodes were placed as far away from recording sites as possible to avoid evoking monosynaptic GABAergic synaptic activities due to directly stimulating interneurons. Certain manipulations were used to prevent neuronal hyperexcitability in GABAergic antagonists: 1) "isolation" of CA1 area was achieved by cutting presynaptic axons in stratum radiatum while leaving oriens/alveaus of hippocampal slices intact; this optimizes the integrity of CA1 neurons (Wang and Kelly 1996a), and 2) the concentration of Mg2+ was 2.4 mM to limit overactivity of synapses. Under these conditions, seizure activity was never observed during basal synaptic transmission and postsynaptic injections of agents; complex waveforms only occurred after tetanic stimulation in a few experiments.

Bipolar tungsten electrodes (12 MOmega ) were positioned in stratum radiatum of CA1 area for orthodromically stimulating schaffer collateral/commisural (S/C) fibers. Certain experiments were conducted with stimulating two independent S/C pathways, in which two electrodes were used (1 was positioned on each side of the recording site in stratum radiatum of CA1 area for orthodromic stimulation), and stimulation was alternated between these two pathways every 2 min. Independent pathways were verified by the observation that excitatory postsynaptic potential (EPSP) or excitatory postsynaptic current (EPSC) amplitudes measured from simultaneous stimulation of both pathways (data points in brackets in Figs. 2, 4, and 5) approximated the algebraic sum of EPSPs or EPSCs when P1 and P2 were stimulated individually (Wang and Kelly 1995). The frequency of test stimuli was 0.05 Hz; high-frequency tetanic stimulation was composed of 10 trains with 5-s intervals (each train contained 10 pulses with 200-Hz frequency) at the same stimulus intensity as test stimulation. Glass microelectrodes (60-85 MOmega ) were filled with 2 M potassium acetate (KAc) or 2 M KAc plus various agents [calcineurin autoinhibitory peptide (CaN-AIP), FK-506, rapamycin, Ca2+/CaM, 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (BAPTA), heparin/dantrolene, a calmodulin-binding peptide (CBP), or CaM-dependent protein kinase II and protein kinase C (CaM-KII/PKC) pseudosubstrate inhibitory peptides [Ala286]CaM-KII281-302 plusPKC19-31]. Synaptic responses in CA1 pyramidal neurons were recorded under current- and voltage-clamp conditions in each set of studies to reduce the limitation inherent to each recording mode (e.g., current clamp is less effective in reducing the shunting effect caused by GABA receptor-channel activity, whereas voltage clamp is limited by space clamp). Pipettes containing 1 M NaCl for field potential recordings were placed in stratum radiatum near intracellular recording sites to verify the viability of tissue slices and status of synaptic activity.


View larger version (32K):
[in this window]
[in a new window]
 
FIG. 2. Tetanus LTP and PPF attenuation are pathway-specific in fEPSPs recordings. Experiments were conducted by alternatively stimulating 2 independent S/C pathways; synaptic responses and PPF during simultaneous stimulation of independent pathways (see METHODS) are represented by symbols in brackets (see also Figs. 4 and 5). A: after recording fEPSPs of 2 pathways for 10 min, tetanic stimulation was given to pathway 1 and induced LTP (R1, open circle ; R2, square ) and PPF attenuation (diamond ; n = 14). B: during LTP in pathway 1, synaptic transmission and PPF was not changed in pathway 2. Tetanic stimulation to P2 at 100 min induced LTP (R1, open circle ; R2, square ) and PPF attenuation (diamond ; n = 7). right-arrow, tetanic stimulation; the break in the x axis indicates a 15-min period during which synaptic responses were not recorded.


View larger version (45K):
[in this window]
[in a new window]
 
FIG. 4. Effects of postsynaptic injections of CaM-KII plus PKC inhibitors on basal synaptic transmission, tetanus-induced LTP and PPF attenuation. A: [Ala286]CaM-KII286-302/PKC19-31 attenuates LTP without significantly affecting basal synaptic transmission. After stable EPSP recordings with 2 M KAc electrodes for 10 min, tetanic stimulation given to pathway 1 (P1, bullet  and black-square) induced LTP (R1, bullet ; R2, black-square), and synaptic transmission in pathway 2 (P2, open circle  and square ) was not significantly changed. KAc electrodes were replaced by the second electrodes containing 200 µM [Ala286]CaM-KII281-302 and 100 µM PKC19-31 in 2 M KAc for impaling a second nearby neuron within 20 min. Manipulations were done very carefully to prevent movement of electrodes, and stimulation intensity was not changed. During subsequent recordings for >100 min, synaptic responses in P1 (R1 and R2, bullet  and black-square) returned to near baseline values (···), and EPSPs in P2 (R1 and R2, open circle  and square ) were not significantly changed. Inset: representative EPSPs showing the effect of [Ala286]CaM-KII286-302/PKC19-31 on LTP in P1; calibration is 20 mV/30 ms. B: [Ala286]CaM-KII286-302/PKC19-31 reverses PPF attenuation induced by tetanus. Left: tetanus-induced PPF attenuation in P1 (black-diamond ) recorded with 2 M KAc electrodes, but PPF in pathway 2 (P2, diamond ) was not significantly changed. Right: postsynaptic injections of [Ala286]CaM-KII281-302 (200 µM in 2 M KAc electrodes) plus PKC19-31 (100 µM) into a second nearby neuron reverse tetanus-induced PPF attenuation in P1 (black-diamond ) without significantly affecting PPF in P2 (diamond ). - - - inhibitor or KAc diffusion into neurons; down-arrow ; tetanus; and [ ] enclose data points with simultaneous stimulation in P1 and P2.


View larger version (34K):
[in this window]
[in a new window]
 
FIG. 5. Effects of postsynaptic injections of heparin/dantrolene on tetanus-induced LTP and PPF attenuation during simultaneous intracellular and extracellular recordings. A: heparin/dantrolene prevent LTP induction. Electrodes containing 300 µM heparin and 80 µM dantrolene were used for recording excitatory postsynaptic currents (EPSCs; bullet  and black-square). After 36 min for diffusion of agents, tetanic stimulation did not induce significant synaptic potentiation of EPSCs (R1, bullet ; R2, black-square) but induced robust LTP of fEPSPs (R1, open circle ; R2, square ). Left inset: EPSC waveforms with no LTP; calibration is 200 pA/30 ms. Right inset: fEPSP with LTP; calibration is 1 mV/20 ms. B: postsynaptic injections of heparin/dantrolene block PPF attenuation of EPSCs (black-diamond ). Simultaneous field potential recordings show PPF attenuation (diamond ). up-arrow , tetanic stimulation; [ ] data points recorded during simultaneous stimulation in 2 pathways (data for nontetanized control pathway not shown).

Experimental results are analyzed only from neurons in which stable recordings were obtained within 2 min after impalement and that exhibited stable membrane potentials at 70-73 mV throughout the experiment. Certain experiments were conducted by discontinuous single electrode voltage-clamp (dSEVC) recordings with 3-kHz sampling rate, and membrane potentials were held at -78 mV (i.e., near the GABAA reversal potential), which may weaken the shunting effect of GABAergic activity on EPSCs. During tetanic stimulation, the dSEVC recording mode was changed briefly to current-clamp mode. Synaptic responses (R) were computed as the initial slopes of EPSPs, EPSCs, or field EPSPs (fEPSPs). The control (baseline) values of EPSPs, EPSCs, and fEPSPs are 8-10 mV, 200-250 pA, and 0.8-1 mV, respectively (~40% of maximal values). The values of PPF were calculated as (R2-R1)/R1 (i.e., relative facilitation). Baseline values (the first data point in each figure) of EPSPs, EPSCs, fEPSPs, or PPF were calculated from synaptic responses during the first minute after stable intracellular recordings were established and defined as 100%. Values of CaN-inhibited synaptic potentiation and PPF changes were from data points 1-3 min before tetanic stimulation compared with baseline, and values of LTP with PPF attenuation were from data points 20 min after tetanus. Synaptic responses are represented as means ± SE. Series and input resistances were monitored throughout all voltage- and current-clamp experiments by measuring responses to 4 mV and 0.1 nA injections (50 ms). Data were obtained with pClamp 5.5 and analyzed with custom software to compute initial EPSP, EPSC, and field EPSP slopes. Student's t-tests were used for statistical comparisons. Waveforms were averaged from six consecutive responses and waveforms in each figure were selected from a representative experiment.

CaN-AIP (3 mM stock in distilled water) was diluted to a final concentration of 300 µM in 2 M KAc. Ca2+/CaM mixtures were prepared from CaCl2 and CaM stock solutions and mixed with CaN-AIP and then diluted to final concentrations of 20/80 µM and 300 µM in 2 M KAc. FK-506 and rapamycin were dissolved in 100% ethanol (50 mM stock solutions) and diluted to a final concentration of 50 µM in 2 M KAc. BAPTA was dissolved in 3 M KOH (400 mM stock, pH 7.2) and diluted to a final concentration of 20 mM in 2 M KAc plus 50 µM FK-506. Heparin and dantrolene were dissolved in 2 M KAc at final concentrations of 300 µM and 80 µM or plus 50 µM FK-506. Stock solutions of CBP or [Ala286]CaM-KII281-302/PKC19-31 in distilled water were diluted to final concentrations of 100 µM or 200 µM/100 µM in 2 M KAc. Microelectrodes were filled completely using these solutions. Bicucullin and BAPTA were purchased from Sigma; heparin, dantrolene, D(-)-2-amino-5-phosphonopentanoic acid(D-AP5) and picrotoxin were from RBI; CaM was gift from Dr. J. Aronowski; CaN-AIP was gift from Dr. Randall Kincaid (Veritas, Rockville, MD); FK-506 and rapamycin were gifts from Dr. Stan Stepkowski (University of Texas Medical School at Houston).

    RESULTS
Abstract
Introduction
Methods
Results
Discussion
References

Tetanus-induced LTP is accompanied by PPF attenuation

It is controversial whether tetanus-induced LTP is accompanied by a change (Christie and Abraham 1994; Kuhnt and Voronin 1994; Schulz et al. 1994, 1995; Voronin and Kuhut 1990) or no change in PPF (Gustafsson et al. 1988; Manabe et al. 1993). We reexamined this issue at CA1 synapses in rat hippocampal slices. First, the dynamic process of PPF during LTP was observed under field potential recordings. As shown in Fig. 1, after recording stable synaptic transmission and PPF for 32 min, tetanic stimulation induced nondecremental LTP (R1, 166 ± 7%; R2, 154 ± 8% relative to baseline 100%) and attenuated PPF [66 ± 5% relative to baseline 100%, n = 14/14 (i.e., 14 of 14 experiments); Fig. 1A]. Similarly, tetanus at 60 min also induced LTP (R1, 169 ± 4%; R2, 153 ± 3%) and PPF attenuation(59 ± 3%, n = 44/44; Fig. 1B). Subsequently, we examined if the PPF attenuation associated with LTP is synapse-specific. Experiments were conducted with alternative test stimulation and sequential tetanic stimulation in two independent pathways (i.e., pathway 1, P1; pathway 2, P2), and results are shown in Fig. 2. After tetanus was given to P1, synapses in P1 expressed robust LTP (R1, 172 ± 9%; R2, 153 ± 6%) and PPF attenuation (56 ± 2%; n = 15/15), whereas P2 did not display changes in basal synaptic transmission (R1, 101 ± 3%; R2, 102 ± 4%) and PPF (109 ± 8%; n = 14/14); both values were obtained at 40-44 min. Tetanic stimulation given to P2 (n = 7/7) at 100 min induced LTP (R1, 165 ± 6%; R2, 159 ± 7%) and PPF attenuation(77 ± 9%). These results indicate that tetanus induces simultaneous changes in synaptic plasticity, i.e., LTP and PPF attenuation, and the changes are synapse-specific. It is noteworthy that simultaneous stimulation to these two independent pathways results in decreased PPF during field potential recordings (brackets in Fig. 2).


View larger version (30K):
[in this window]
[in a new window]
 
FIG. 1. Tetanus long-term potentiation (LTP) is accompanied by attenuation of paired-pulse facilitation (PPF) in recordings of field excitatory postsynaptic potentials (fEPSPs). A: tetanic stimulation was given to Schaffer collateral/commisural (S/C) pathways 32 min after stable synaptic transmission and induced potentiation of synaptic responses (open circle , the 1st response R1; square , the 2nd response R2) and attenuation of PPF((R2-R1)/R1, diamond ; n = 14). B: tetanic stimulation 60 min after stable fEPSP recordings induced LTP (R1 and R2) and PPF attenuation (n = 44). Inset: representative fEPSPs; calibration is 1 mV/20 ms; right-arrow, tetanic stimulation.

We further examined these results under intracellular recordings (dSEVC mode) with electrodes containing 50 µM rapamycin. Basal synaptic transmission and PPF were not changed. Tetanic stimulation at 60 min induced robust LTP (R1, 184 ± 10%; R2, 157 ± 7%) and PPF attenuation(53 ± 10%; n = 5/5; Fig. 3). Rapamycin binds CaN-anchoring proteins (FK-506 binding proteins, FKBPs) without affecting CaN activity (MacKintosh and MacKintosh 1994; Schreiber and Crabtree 1992; Wiederrecht et al. 1989) and was used as a control for FK-506 experiments (see below). These results further indicate that tetanus-induced LTP is associated with PPF attenuation under a variety of experimental conditions.


View larger version (26K):
[in this window]
[in a new window]
 
FIG. 3. Tetanus LTP is accompanied by PPF attenuation under voltage-clamp recordings. After recording stable synaptic transmission for 60 min, tetanic stimulation induced LTP (R1, open circle ; R2, square ) and PPF attenuation (diamond ; n = 5). Pipettes contained 50 µM rapamycin in 2 M potassium acetate (KAc; control for FK-506 experiments). Inset: representative excitatory postsynaptic current (EPSC) waveforms; calibration is 250 pA/30 ms; right-arrow, tetanic stimulation.

Postsynaptic injections of CaM-KII and PKC pseudosubstrate inhibitors suppress LTP maintenance and reverse PPF attenuation

Experiments were conducted by sequentially recording two nearby CA1 neurons with KAc- and [Ala286]CaMKII281-302/PKC19-31-containing pipettes and alternatively stimulating two independent S/C pathways. Figure 4 shows effects of postsynaptic injections of [Ala286]CaMKII281-302 plus PKC19-31 on established LTP and PPF attenuation. In the first part of experiments, a 2 M KAc pipette was used to impale a CA1 pyramidal neuron. After getting stable control values of synaptic transmission and verifying two independent pathway stimulation (see METHODS), tetanus was delivered to P1. Synaptic responses displayed typical LTP (R1 196 ± 21% relative to baseline 100%; R2, 152 ± 19%; Fig. 4A) and PPF attenuation(39 ± 12%; n = 7/7; Fig. 4B) in P1, but little if any change of basal synaptic transmission (R1, 118 ± 10%; R2, 117 ± 8%) and PPF (103 ± 11%) in P2. After 40 min, the KAc pipette was withdrawn carefully, and another pipette containing 200 µM [Ala286]CaMKII281-302 and 100 µM PKC19-31 was used to impale a second CA1 neuron near the first one (this manipulation was accomplished within 20 min). Synaptic responses in P1 and P2 were monitored continuously for an additional 120 min and normalized relative to the first data point of basal synaptic responses recorded from the first neuron in P1 and P2.

The second part of the experiments shows the effect ofpseudosubstrate inhibitors of CaM-KII and PKC on synaptic transmission and PPF in potentiated and basal pathways. The postsynaptic injections of [Ala286]CaM-KII281-302 and PKC19-31 significantly decreased prepotentiated synaptic transmission (R1, 133 ± 22% relative to 254 ± 37%; R2, 130 ± 21% relative to 204 ± 26%; n = 7/7; P < 0.002; Fig. 4A, bullet  and black-square) and reversed PPF attenuation close to baseline values within 90 min (102 ± 12%; n = 7/7; P < 0.01; Fig. 4B, black-diamond ) in P1 but had little effect on basal synaptic transmission (R1, 107 ± 12%; R2, 114 ± 12%) and PPF (122 ± 13%) in P2. These results indicate that postsynaptic CaM-KII/PKC activities triggered by tetanus are responsible for maintaining synaptic potentiation and PPF attenuation. It is noteworthy that simultaneous stimulation to these two independent pathways results in decreased PPF during intracellular recording with 2 M KAc (Fig. 4, [black-diamond ]).

Postsynaptic injections of heparin plus dantrolene prevent LTP induction and PPF attenuation

Our results showed that the increases in postsynaptic Ca2+, Ca2+/CaM, or Ca2+-dependent protein kinase activities (e.g., CaM-KII and PKC) play an important role in synaptic potentiation and PPF attenuation (Wang and Kelly 1996) (Fig. 4). To define the source of Ca2+ for these changes, we examined whether postsynaptic Ca2+ increases are due to N-methyl-D-aspartate (NMDA) receptor activation (see Fig. 8), release from intracellular Ca2+ stores by inositol-1,4,5-triphosphate (IP3) and ryanodine (Ry) receptor-channels (Ghosh and Greenberg 1995) or both. Heparin and dantrolene were selected for inhibiting activities of IP3R and RyR (Ohta 1990; Smith and Gallacher 1994). Experiments were conducted under the condition of simultaneous intracellular and field potential recordings as shown in Fig. 5. Postsynaptic injections of heparin plus dantrolene had little if any effect on basal synaptic transmission but prevented tetanus-induced LTP (R1, 112 ± 1%; R2, 117 ± 9%; Fig. 5A, bullet  and black-square) and PPF attenuation (115 ± 17%; Fig. 5B, black-diamond ; n = 5/5) compared with the values of LTP and PPF in simultaneous field potential recordings (R1, 159 ± 2.5%; R2, 130 ± 1%; PPF, 46 ± 5%). These results indicate that tetanus triggers postsynaptic Ca2+ release from intracellular stores by IP3R and RyR, which is responsible for LTP induction and PPF attenuation. Interestingly, the decreases in PPF by simultaneously stimulating two independent pathways in field potential recordings (open circle , square , and diamond ) were not observed under intracellular recordings with heparin/dantrolene-containing electrodes (Fig. 5B, [black-diamond ]).


View larger version (43K):
[in this window]
[in a new window]
 
FIG. 8. Postsynaptic injections of FK-506 induce synaptic potentiation and PPF attenuation in D(-)-2-amino-5-phosphonopentanoic acid (D-AP5; 40 µM) under simultaneous intracellular and extracellular recordings. A: voltage-clamp recordings with pipettes containing 50 µM FK-506. open circle  and square , R1 and R2 potentiation, respectively; diamond , PPF attenuation. Tetanic stimulation (up-arrow  at 40 min) did not affect the action of FK-506. Inset: representative EPSCs; calibration is 250 pA/30 ms. B: simultaneous field potential recordings show that D-AP5 attenuates LTP (R1, open circle ; R2, square ) and PPF attenuation (diamond ). Inset: representative fEPSPs; calibration is 1 mV/20 ms.

CaN-inhibited synaptic potentiation is accompanied by PPF attenuation

Ca2+/CaM-induced synaptic potentiation and tetanus LTP, which share similar postsynaptic mechanisms (Wang and Kelly 1995), are associated with PPF attenuation (Wang and Kelly 1996b) (Figs. 1-3). Are other types of synaptic potentiation initiated by postsynaptic mechanisms, e.g., CaN-inhibited synaptic potentiation (Wang and Kelly 1996a), also associated with PPF attenuation? We first examined the effect of CaN-AIP (Hashimoto et al. 1990) on synaptic transmission and PPF. Figure 6A shows that postsynaptic injections of CaN-AIP (300 µM in pipette) induced synaptic potentiation (R1, 202 ± 14%; R2, 172 ± 12%) and PPF attenuation (60 ± 8%; n = 6/6). Interestingly, subsequent tetanus induced synaptic depotentiation in R1 (153 ± 13%) but not R2 (168 ± 6%) and reversed PPF attenuation (95 ± 10%; n = 6/6). We also examined the effect of postsynaptic injections of CaN-AIP plus Ca2+/CaM on synaptic transmission and PPF (Fig. 6B). Intracellular recordings with pipettes containing 300 µM CaN-AIP and 80/20 µM Ca2+/CaM displayed synaptic potentiation (R1, 183 ± 10%; R2, 138 ± 10%) and PPF attenuation (40 ± 7%; n = 7/7). Subsequent tetanus induced synaptic depotentiation in R1 (165 ± 8%) but not R2 (154 ± 2%) and reversed PPF attenuation (99 ± 11%; n = 7/7). These results demonstrate that CaN-AIP-induced synaptic potentiation is accompanied by PPF attenuation. It is noteworthy that PPF attenuation by CaN-AIP plus Ca2+/CaM (40 ± 7%; Fig. 6B) is significantly larger than that by CaN-AIP (60 ± 8%, Fig. 6A; P < 0.017), which may be due to the synergistic effect of CaN-AIP plus Ca2+/CaM on PPF.


View larger version (46K):
[in this window]
[in a new window]
 
FIG. 6. Effects of postsynaptic injections of calcineurin autoinhibitory peptide CaN-AIP, or CaN-AIP plus Ca2+/CaM on synaptic transmission and PPF. A: CaN-AIP induces synaptic potentiation and PPF attenuation. Pipettes containing 300 µM CaN-AIP were used for intracellular recordings and postsynaptic injections. open circle  and square , R1 and R2 potentiation, respectively; diamond , PPF attenuation. Inset: representative EPSPs; calibration is 20 mV/30 ms. B: Ca2+/CaM plus CaN-AIP induce synaptic potentiation (R1, open circle ; R2, square ) and PPF attenuation (diamond ). Inset: representative EPSPs (same calibration bars as waveforms in A). up-arrow , tetanic stimulation. Tetanus at 60 min in A and B results in synaptic depotentiation of R1 and reverses PPF attenuation.

To further examine the effect of postsynaptic CaN activity on synaptic transmission and PPF, we used another CaN inhibitor, FK-506, which inhibits CaN activity by binding to FKBPs (e.g., FKBP-12) and is a much more potent (IC50 ~30 nM) (Dawson et al. 1994; MacKintosh and MacKintosh 1994; Schreiber and Crabtree 1992; Steiner et al. 1992; Wiederrecht et al. 1989) than CaN-AIP (IC50 ~10 µM) (Hashimoto et al. 1990). Figure 7 shows the result of injecting FK-506 (50 µM in pipette) into postsynaptic neurons under voltage-clamp recordings. Postsynaptic injections of FK-506 induced a gradual synaptic potentiation (R1, 207 ± 13%; R2, 169 ± 12% at 60 min) and decreased PPF (32 ± 6%; n = 6/6; Fig. 7A). This result together with CaN-AIP results indicate that CaN-inhibited synaptic potentiation is associated with PPF attenuation. CaN-inhibited synaptic potentiation with PPF attenuation further indicates that postsynaptic CaN activity limits synaptic transmission and facilitates paired-pulse responses under basal conditions. The effect of tetanus on FK-506-induced synaptic potentiation is shown in Fig. 7B. After synaptic potentiation (R1, 220 ± 16%; R2, 183 ± 11% at 32 min) and PPF attenuation(31 ± 7%), tetanic stimulation produced synaptic depotentiation (R1, 189 ± 17%; R2, 168 ± 18%; P = 0.021 for R1 comparison) and reversed PPF attenuation (65 ± 11%; n = 6/6; P = 0.008; 20 min posttetanus). The reversal of CaN-inhibited PPF attenuation by tetanus appeared to result from the larger synaptic depotentiation in R1 relative to R2.


View larger version (48K):
[in this window]
[in a new window]
 
FIG. 7. Postsynaptic injections of FK-506 induces synaptic potentiation and PPF attenuation (A and B). Pipettes containing 50 µM FK-506 were used for intracellular recordings and postsynaptic injections. open circle  and square , R1 and R2 potentiation, respectively; diamond , PPF attenuation. Inset: representative EPSCs; calibration is 250 pA/30 ms. Tetanic stimulation (up-arrow  at 32 min in B) results in synaptic depotentiation and partially reverses PPF attenuation.

CaN-inhibited synaptic potentiation and PPF attenuation require postsynaptic Ca2+ signaling pathways

Further evidence for the associated changes in CaN-inhibited synaptic potentiation and PPF attenuation was obtained by testing if certain manipulations simultaneously prevented CaN-inhibited synaptic potentiation and PPF attenuation. As CaN-inhibited synaptic potentiation occludes tetanus LTP (Figs. 6 and 7) and LTP induction requires NMDA receptor activation (Collingridge et al. 1983a,b) and postsynaptic Ca2+ (Lynch et al. 1983), we examined the effects of blocking NMDA receptor activation or postsynaptic Ca2+ signaling pathways. First, the role of NMDA receptors was tested. Simultaneous intracellular (dSEVC) and extracellular recordings were conducted in presence of 40 µM D-AP5; pipettes contained 50 µM FK-506. As shown in Fig. 8, FK-506 induced synaptic potentiation (R1, 211 ± 12%; R2, 186 ± 13% at 40 min) and PPF attenuation (66 ± 6%). Subsequent tetanus did not decrease CaN-inhibited synaptic potentiation (R1 237 ± 20%; R2 200 ± 14 at 72 min) and PPF attenuation (60 ± 8%; n = 5/5; Fig. 8A). However, compared with results in Figs. 1 and 2, D-AP5 attenuated LTP magnitude in field potential recordings (R1, 117 ± 5%; R2, 113 ± 4%; Fig. 8B) and prevented PPF attenuation (85 ± 22%; P = 0.09). This result indicates that NMDA receptor activation does not contribute to CaN-inhibited synaptic potentiation and PPF attenuation. The small tetanus-LTP of fEPSPs in D-AP5 (Fig. 8B) may be similar to the NMDA-independent LTP reported previously (Grover and Tyler 1990).

Next, the role of postsynaptic Ca2+ signaling pathways was examined. Pipettes containing 50 µM FK-506 with 40 mM BAPTA in 2 M KAc were used for intracellular recordings (dSEVC) in CA1 neurons. Figure 9A shows that postsynaptic coinjections of BAPTA significantly decreased FK-506-induced synaptic potentiation (R1, 117 ± 5%relative to 207 ± 11%; P = 0.0008) and PPF attenuation (101 ± 10% relative to 32 ± 6%; P = 0.0004; n = 6/6). This result indicates that postsynaptic Ca2+ increases are responsible for CaN-inhibited synaptic potentiation and PPF attenuation. Because D-AP5 did not affect the result of FK-506 injections (Fig. 8), another source for postsynaptic Ca2+ increases (e.g., intracellular stores) was examined. Heparin and dantrolene, which inhibit IP3R and RyR activities, respectively (Ohta 1990; Smith and Gallacher 1994), were coinjected with FK-506 into CA1 neurons. Figure 9B shows that heparin/dantrolene significantly decrease FK-506-induced synaptic potentiation (R1, 124 ± 5% relative to207 ± 11%; P = 0.0009) and PPF attenuation (113 ± 10% relative to 32 ± 6%; P = 0.0008; n = 8/8). This result indicates that Ca2+ comes from intracellular release by IP3 and ryanodine receptors.


View larger version (49K):
[in this window]
[in a new window]
 
FIG. 9. Postsynaptic coinjections of 1,2-bis(2-aminophenoxy)-ethaneN,N,N',N'-tetraacetic acid (BAPTA) or heparin/dantrolene blockFK-506-induced synaptic potentiation and PPF attenuation. A: BAPTA attenuates the effect of FK-506. Pipettes containing 40 mM BAPTA with 50 µM FK-506 were used for intracellular recordings; coinjection results R1 (bullet ) and PPF (black-diamond ) compared with the effects of FK-506 alone on synaptic transmission (open circle ) and PPF (diamond ). Inset: representative EPSCs from coinjecting FK-506 plus BAPTA; calibration is 250 pA/30 ms. B: heparin/dantrolene attenuates the effects of FK-506. Pipettes containing 300 µM heparin and 80 µM dantrolene plus 50 µM FK-506 were used for intracellular recording; coinjection results R1 (bullet ) and PPF (black-diamond ) compared with FK-506 alone (open circle  and diamond ). Inset: representative EPSCs from coinjecting heparin/dantrolene with FK-506 at the time points of 1 and 2; calibration is 250 pA/30 ms.

We further examined the role of Ca2+ and CaM downstream targets in CaN-inhibited synaptic potentiation and PPF attenuation. A high-affinity CBP (Hanley et al. 1988; Kelly et al. 1989) was used. Pipettes containing 100 µM CBP plus 50 µM FK-506 in 2 M KAc were used to impale CA1 neurons for intracellular recordings and postsynaptic coinjections. Figure 10A shows that CBP significantly decreased FK-506-induced synaptic potentiation (R1, 101 ± 9% relative to 207 ± 11%; P = 0.00004) and PPF attenuation (119 ± 16% relative to 32 ± 6%; P = 0.0008; n =7/7). This result indicates that active Ca2+/CaM serves as a functional element in CaN-inhibited synaptic potentiation and PPF attenuation. As Ca2+/CaM-induced synaptic potentiation and PPF attenuation require CaM-KII and PKC activities (Wang and Kelly 1995, 1996), we tested if CaN-inhibited synaptic effects require CaM-KII and PKC activities. Pseudosubstrate inhibitors of CaM-KII and PKC, [Ala286]CaM-KII281-302 (100 µM) and PKC19-31 (100 µM) (Hanson et al. 1994; Kemp 1994) plus FK-506 (50 µM) in 2 M KAc were coinjected into postsynaptic neurons. Figure 10B shows that [Ala286]CaM-KII281-302 and PKC19-31 significantly decreased FK-506-induced synaptic potentiation (R1, 123 ± 11% relative to 207 ± 11%; P = 0.0008) and PPF attenuation (110 ± 10% relative to 32 ± 6%; P = 0.0009; n = 7/7). This result indicates that postsynaptic CaM-KII/PKC activities are involved in CaN-inhibited synaptic potentiation and PPF attenuation.


View larger version (48K):
[in this window]
[in a new window]
 
FIG. 10. Postsynaptic coinjections of CBP, or [Ala286]CaM-KII286-302/PKC19-31 block FK-506-induced synaptic potentiation and PPF attenuation. A: calmodulin-binding peptide (CBP) attenuates the effects of FK-506. Pipettes containing 100 µM CBP with 50 µM FK-506 were used for intracellular recordings; coinjection results R1 (bullet ) and PPF (black-diamond ) compared with the effects of FK-506 alone on synaptic transmission (open circle ) and PPF (diamond ). Inset: representative EPSCs from coinjecting FK-506 plus CBP; calibration is 250 pA/30 ms. B: [Ala286]CaM-KII286-302/PKC19-31 attenuates the effects of FK-506. Pipettes containing 200/100 µM CaM-KII286-302/PKC19-31 with 50 µM FK-506 were used for intracellular recordings; coinjection results R1 (bullet ) and PPF (black-diamond ) compared with FK-506 alone (open circle  and diamond ). Inset: representative EPSCs from coinjecting [Ala286]CaM-KII286-302/PKC19-31 with FK-506 at the time points of 1 and 2; calibration is 250 pA/30 ms.

    DISCUSSION
Abstract
Introduction
Methods
Results
Discussion
References

Our results show that tetanus LTP is accompanied by PPF attenuation in extracellular or intracellular recordings (Figs. 1-3); this supports previous reports (Christie and Abraham 1994; Kuhnt and Voronin 1994; Schulz et al. 1994, 1995; Voronin and Kuhut 1990). Based on the hypothesis that PPF is generated by presynaptic residual Ca2+ (Magleby 1987; Zucker 1989), previous authors suggested that the mechanisms of LTP expression are presynaptic. However, we found that postsynaptic injections of IP3R/RyR inhibitors prevented tetanus-LTP induction and PPF attenuation (Fig. 5), and CaM-KII/PKC pseudosubstrate inhibitors significantly attenuated LTP maintenance and reversed PPF attenuation (Fig. 4). These results strongly suggest that PPF attenuation associated with LTP is regulated by postsynaptic mechanisms. We reported that postsynaptic Ca2+/CaM-induced synaptic potentiation is accompanied by PPF attenuation (Wang and Kelly 1996b). We now show that PPF attenuation is associated with synaptic potentiation induced by inhibiting postsynaptic CaN activity (Figs. 6-10). These associated changes in synaptic potentiation and PPF attenuation rely on postsynaptic Ca2+ and Ca2+/CaM signaling mechanisms. Taking all of these results together, we conclude that postsynaptic mechanisms contribute to both LTP expression and PPF modulation and suggest that changes in PPF should not be a criteria for assigning a presynaptic location for LTP expression because postsynaptic biochemical manipulations alter PPF.

Ca2+/CaM-induced or CaN-inhibited synaptic potentiation occlude tetanus LTP (Wang and Kelly 1995, 1996a) (Figs. 6 and 7). All three forms of synaptic potentiation and associated PPF attenuation require postsynaptic Ca2+/CaM signaling pathways (Wang and Kelly 1996b) (Figs. 4, 5, 9, and 10). Thus they may share common mechanisms, i.e., increases in postsynaptic Ca2+/CaM levels and CaM-KII/PKC activities. Moreover, synaptic potentiation and associated PPF attenuation may require a positive feedback mechanism to maintain persistent expression. In this study, we found that PPF attenuation associated with CaN-inhibited synaptic potentiation and tetanus-LTP required postsynaptic Ca2+ release from intracellular stores by IP3Rs and RyRs (Figs. 5 and 9). Together with biochemical studies showing that IP3Rs and RyRs are phosphorylated by CaM-KII/PKC and dephosphorylated by CaN (Cameron et al. 1995; Furuichi and Mikoshiba 1995; Hain et al. 1995; Snyder and Sabatini 1995), the phosphorylation of IP3Rs increases receptor sensitivity to IP3 (Cameron et al. 1995), and the phosphorylation of RyRs by CaM-KII activates this receptor (Takasawa et al. 1995), we hypothesize that postsynaptic Ca2+ stores are a critical site for this positive feedback, i.e., the phosphorylation of IP3R and RyRs facilitates further increases in Ca2+ and Ca2+/CaM signaling pathways.

Our previous results indicate that Ca2+/CaM-induced PPF attenuation is due to an increase in AMPA receptor desensitization through CaM-KII/PKC activity (Wang and Kelly 1996b). As tetanus LTP and CaN-inhibited synaptic potentiation share common mechanisms with Ca2+/CaM-induced synaptic potentiation, PPF attenuation associated with CaN-inhibited synaptic potentiation and tetanus-LTP may be due to an increase of AMPA receptor desensitization. If each one of these postsynaptic manipulations enhances CaM-KII/PKC activity and then increases AMPA receptor desensitization while increasing receptor sensitivity, their combination may produce higher levels of AMPA receptor desensitization than each alone. The final read-out of receptor responsiveness, which reflects the equilibrium between receptor sensitivity and desensitization (Wang and Kelly 1996b), may account for why postsynaptic injections of Ca2+/CaM plus CaN-AIP did not induce additive synaptic potentiation but induced a larger PPF attenuation than CaN-AIP alone (Fig. 6) and why tetanus induced synaptic depotentiation after CaN-inhibited or Ca2+/CaM-induced synaptic potentiation (Wang and Kelly 1995) (Figs. 6 and 7).

Certain reports seem to argue against a role of affecting postsynaptic AMPA receptors in modulating synaptic facilitation, in which the partial block of AMPA receptor activity by 6-cyano-7-nitroquinoxaline-2,3-dione did not change PPF (Manabe et al. 1993; Schulz et al. 1994) and PPF of EPSC amplitude was independent of membrane potentials (Clark et al. 1994; Manabe et al. 1993). These manipulations either reduce the number of active AMPA receptors or change the electrical driving force for ions through channels but are not believed to modify biochemical properties of an individual receptor; this may explain why these manipulations produce parallel changes in R1 and R2. Our protocols involved activating postsynaptic Ca2+/CaM signaling pathways or inhibiting CaN, which enhance protein phosphorylation (e.g., the biochemical modification of receptors) such that receptor sensitivity and desensitization are increased, which together are responsible for synaptic potentiation and PPF attenuation.

During the assessment of pathway independence in two-pathway experiments, we observed that additive synaptic responses by simultaneous stimulation of two independent S/C pathways was associated with a decrease in PPF (Figs. 2, 4, and 5, [ ]) that was due to the decreased summation of R2 compared with R1. This observation may be similar to the result in which PPF decreased during increasing stimulus intensity in one pathway (Dumas and Foster 1995). It is difficult to explain this PPF decrease, which is caused by activating two independent groups of synapses, by presynaptic mechanisms if there is no change in postsynaptic receptor properties. Because of the role of presynaptic residual Ca2+ during the second stimulation, the increases in transmitter release at the two groups of synapses should result in linear summation in R2 similar to R1. Alternatively, this PPF decrease may result from interactions among synapses. If the interaction is presynaptic in origin (e.g., presynaptic inhibition), it is difficult to understand why postsynaptic injections of heparin plus dantrolene prevented this PPF decrease (Fig. 5B, [black-diamond ]), in which heparin and dantrolene appear to attenuate R1 summation with less effect on R2 summation. The mechanism for this phenomenon remains to be elucidated.

Our results show that synaptic potentiation and PPF attenuation induced by tetanus, activation of postsynaptic Ca2+/CaM signaling pathways, or inhibition of postsynaptic CaN activity require postsynaptic Ca2+ mobilization and CaM-KII/PKC activities. One could argue that our postsynaptic manipulations may induce the production of retrograde messengers [e.g., nitric oxide (NO)], which in turn enhance presynaptic transmitter release (Garthwaite 1991). Although our results cannot rule out this possibility, the phosphorylation of NO synthase (NOS) by PKC or CaM-KII reduces its catalytic activity and decreases NO production (Steiner et al. 1996), i.e., weakening the index of NO function. Thus the precise role of retrograde messengers in regulating PPF remains to be further explored. We conclude that postsynaptic Ca2+ and Ca2+/CaM signaling pathways play an important role in regulating synaptic strength and synaptic facilitation. As Ca2+/CaM and/or Ca2+ activate CaN and CaM-KII/PKC, we suggest that these postsynaptic signaling pathways play a dual role in synaptic strength and facilitation, i.e., CaN activity limits synaptic strength (Wang and Kelly 1996a) associated with larger synaptic facilitation, whereas increased CaM-KII/PKC activities enhance synaptic strength with attenuated synaptic facilitation. As the magnitude of PPF is regulated by postsynaptic Ca2+ and Ca2+/CaM signaling pathways, changes in PPF should not be a criteria for judging the location of mechanisms responsible for the expression of synaptic potentiation.

    ACKNOWLEDGEMENTS

  We thank Drs. Jarek Aronowski for calmodulin, Randall Kincaid for CaN-AIP, Stan Stepkowski for FK-506 and rapamycin, and Michael Mauk for analysis software.

  This study was supported by National Institute of Neurological Disorders and Stroke Grant NS-32470.

    FOOTNOTES

  Address reprint requests to: P. T. Kelly, Dept. of Neurobiology and Anatomy, University of Texas, Medical School, Houston, PO Box 20708, Houston, TX 77225. E-mail: pkelly{at}nba19.tmc.uth.edu

  Received 2 April 1997; accepted in final form 1 July 1997.

    REFERENCES
Abstract
Introduction
Methods
Results
Discussion
References

0022-3077/97 $5.00 Copyright ©1997 The American Physiological Society